OS Therapies OSTX EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from OS Therapies’s reported figures.
The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about OS Therapies's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OS Therapies's EBITDA?
- OS Therapies (OSTX) reported EBITDA of -$10.04M in Q1 2026.
- How has OS Therapies's EBITDA changed year-over-year?
- OS Therapies's EBITDA decreased by 100.9% year-over-year, from -$5M to -$10.04M.
- What is the long-term trend for OS Therapies's EBITDA?
- Over 2 years (2023 to 2025), OS Therapies's EBITDA has grown at a 155.6% compound annual growth rate (CAGR), from -$4.34M to -$28.34M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.